These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38403546)

  • 1. KRIT1 could serve as a prognostic biomarker for glioma patients.
    Zhou X; Shao F; Xie Y; Zhang C
    Asian J Surg; 2024 May; 47(5):2247-2249. PubMed ID: 38403546
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARL3 is downregulated and acts as a prognostic biomarker in glioma.
    Wang Y; Zhao W; Liu X; Guan G; Zhuang M
    J Transl Med; 2019 Jun; 17(1):210. PubMed ID: 31234870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients.
    Chen P; Zhang G; Zhou Q; Li Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF2 as a potential prognostic biomarker for proneural glioma patients.
    Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
    Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.
    Zhou C; Zhang Y; Dai J; Zhou M; Liu M; Wang Y; Chen XZ; Tang J
    Sci Rep; 2016 Feb; 6():22066. PubMed ID: 26902498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-599 as a potential biomarker for prognosis of glioma.
    Zhu XY; Li GX; Liu ZL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):294-298. PubMed ID: 29424886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic role of orphan receptor GPR110 in glioma.
    Shi H; Zhang S
    Biochem Biophys Res Commun; 2017 Sep; 491(2):349-354. PubMed ID: 28728843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science.
    Hochberg FH; Atai NA; Gonda D; Hughes MS; Mawejje B; Balaj L; Carter RS
    Expert Rev Mol Diagn; 2014 May; 14(4):439-52. PubMed ID: 24746164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.
    Yang Y; Zhang C; Li L; Gao Y; Luo X; Zhang Y; Liu W; Fei Z
    World J Surg Oncol; 2012 Aug; 10():169. PubMed ID: 22913315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of the SPOP gene is associated with poor prognosis in glioma.
    Ding D; Song T; Jun W; Tan Z; Fang J
    Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
    Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
    Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating biomarkers for high-grade glioma.
    Loo HK; Mathen P; Lee J; Camphausen K
    Biomark Med; 2019 Feb; 13(3):161-165. PubMed ID: 30806515
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Biomarker ZNF311 and Its Correlation With Tumor Progression and Immune Infiltrates in Glioma.
    Ge X; Jiang S; Wang Z; Hu N; Jiang R; Cai Z; Wu B; Zhang Y; Gong P
    World Neurosurg; 2021 Jul; 151():e37-e46. PubMed ID: 33746099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma.
    Wang J; Che F; Zhang J; Zhang M; Xiao S; Liu Y; Zhou L; Su Q; You C; Lu Y; Heng X
    World Neurosurg; 2019 May; 125():e1217-e1225. PubMed ID: 30794970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.